DR ANTHONY MELVIN CRASTO,WorldDrugTracker, helping millions, A 90 % paralysed man in action for you, I am suffering from transverse mylitis and bound to a wheel chair,With death on the horizon, This will not stop me, Gods call only..........
DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai) , INDIA 29Yrs Exp. in the feld of Organic Chemistry,Working for GLENMARK PHARMA at Navi Mumbai, INDIA. Serving chemists around the world. Helping them with websites on Chemistry.Million hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contributio
n
Showing posts with label LTD. Show all posts
Showing posts with label LTD. Show all posts

Tuesday, 12 July 2016

Zai-Xin Chen, Director of R&D Center at Jiangsu Yabang Pharmaceutical Group Co., Ltd

Zai-Xin Chen

Director of R&D Center at Jiangsu Yabang Pharmaceutical Group Co., Ltd

Changzhou Yabang Pharmaceutical Co., LTD.


LINKS
zaixin_chen@163.com

Experience




Postdoctoral Researcher

RWTH Aachen University
 –  (1 year 7 months)Aachen, Germany

Education




Chengdu University of Science and Technology



Jiangsu Yabang Pharmaceutical Group Co., Ltd

JIANGSU YABANG GROUP COYabang Chemical Group Co., Ltd is one of key 100 cultivation enterprises of JiangSu Province, high-tech enterprises in Jiangsu Province, the State Torch Program key high-tech enterprises, with a post-doctoral research station and provincial level technical center, ranked as one of the top 50 in China's petrochemical industry. "YABANG "trademark is approved by the State Administration for Industry and Commerce Trademark Office as" China's well-known trademarks. " Yabang Chemical Group Co., Ltd. always adheres to the business philosophy as "people-oriented, technology-first, quality and the credit as the most important things", adheres to the strategic objectives as "to fight for the No.1 in the industry in China, and to fight for the No.1 in the products in the world" and to develop well and fast! Yabang chemicals group is approved by the National Administration for Industry and Commerce as a private enterprises group with the Yabang Chemical Group Co., Ltd. as the core , which is trans-regional and cross-sectoral, integrating science, industry, and trade as a whole. Now under the Group, there are four major industries as dyes, paints, pharmaceutical, real estate. The Group has More than 7,000 employees, covers an area of 2.8 million square meters, with total assets of 3 billion yuan. In 2006, the sales amounted to 6 billion yuan, creating profits and taxes 450 million yuan.




REGIOMER OF BESIFLOXACIN



STR1

Abstract: In this paper (R)-7-(azepan-3-ylamino)-8-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride 1 was isolated and identified as the N-substituted regioisomer of besifloxacin, which has been synthesized from the reaction of 8-chloro-1-cyclopropyl-6,7-difluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid 3 with (R)-tert-butyl 3-aminoazepane-1-carboxylate 2 in acetonitrile as solvent in 37% yield. The chemical structure of compound 1 was established on the basis of 1H-NMR, 13C-NMR, mass spectrometry data and elemental analysis.
Structural Characterization
1H-NMR (500 MHz, DMSO-d6): δ ppm: 14.73 (H-23, s, 1H), 9.72 (H-14, s, 2H), 8.69 (H-7, s, 1H),7.79 (H-1, d, J = 13.1 Hz, 1H), 6.20 (H-11, d, J = 9.1 Hz, 1H), 4.37 (H-12 and H-19, m, 2H), 3.38(H-13, m, 2H), 3.23 (H-15, m, 1H), 3.09 (H-15, m, 1H), 2.14 (H-18, m, 1H), 1.94 (H-16 and H-18, m,2H), 1.84 (H-16 and H-17, m, 2H), 1.60 (H-17, m, 1H), 1.23 (H-20 or H-21, m, 2H), 1.03 (H-20 orH-21, m, 2H).
13C-NMR(125 MHz, DMSO-d6): δ ppm: 175.6 (C-9), 165.4 (C-22), 151.7 (C-7), 150.6 (C-2), 148.7(C-3), 139.0 (C-5), 137.3 (C-4), 117.8 (C-10), 110.3 (C-1), 107.0 (C-8), 52.9 (C-12), 50.1 (C-13), 46.2(C-15), 41.3 (C-19), 34.0 (C-18), 24.9 (C-16), 21.6 (C-17), 10.9 (C-20 or C-21).
FAB-MS, m/z = 394.1 (M+).
Elemental analysis: Calculated for C19H21ClFN3O3.HCl: C, 53.03%; H, 5.15%; N, 9.77%; found: C,52.82%; H, 5.39%; N, 9.50%.

1H-NMR (500 MHz, DMSO-d6): δ ppm: 14.73 (H-23, s, 1H), 9.72 (H-14, s, 2H), 8.69 (H-7, s, 1H), 7.79 (H-1, d, J = 13.1 Hz, 1H), 6.20 (H-11, d, J = 9.1 Hz, 1H), 4.37 (H-12 and H-19, m, 2H), 3.38 (H-13, m, 2H), 3.23 (H-15, m, 1H), 3.09 (H-15, m, 1H), 2.14 (H-18, m, 1H), 1.94 (H-16 and H-18, m,2H), 1.84 (H-16 and H-17, m, 2H), 1.60 (H-17, m, 1H), 1.23 (H-20 or H-21, m, 2H), 1.03 (H-20 orH-21, m, 2H).
STR1

 

STR1

13C-NMR(125 MHz, DMSO-d6): δ ppm: 175.6 (C-9), 165.4 (C-22), 151.7 (C-7), 150.6 (C-2), 148.7(C-3), 139.0 (C-5), 137.3 (C-4), 117.8 (C-10), 110.3 (C-1), 107.0 (C-8), 52.9 (C-12), 50.1 (C-13), 46.2(C-15), 41.3 (C-19), 34.0 (C-18), 24.9 (C-16), 21.6 (C-17), 10.9 (C-20 or C-21).

STR1

PAPER

Molbank 20132013(2), M801; doi:10.3390/M801
Short Note
(R)-7-(Azepan-3-ylamino)-8-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid Hydrochloride
Supplementary File 3:Support Information (PDF, 340 KB)
Download PDF [188 KB, 27 May 2013; original version 22 May 2013]
R&D Center, Jiangsu Yabang Pharmaceutical Group, Changzhou 213200, China
In this paper (R)-7-(azepan-3-ylamino)-8-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride 1was isolated and identified as the N-substituted regioisomer of besifloxacin, which has been synthesized from the reaction of 8-chloro-1-cyclopropyl-6,7-difluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid 3 with (R)-tert-butyl 3-aminoazepane-1-carboxylate 2in acetonitrile as solvent in 37% yield. The chemical structure of compound 1 was established on the basis of 1H-NMR, 13C-NMR, mass spectrometry data and elemental analysis
REGIOMER OF BESIFLOXACIN

Besifloxacin.pngBESIFLOXACIN

STR1

STR1

 

 Zaixin Chen *
R&D Center, Jiangsu Yabang Pharmaceutical Group, Changzhou 213200, China
* Author to whom correspondence should be addressed;

E-Mail: zaixin_chen@163.com.


CHANGZHOU





















///////////

Saturday, 7 March 2015

WUXI JINXIN BIOSCIENCES CO., LTD 无锡金昕生物科技有限公司



WUXI JINXIN BIOSCIENCES CO., LTD China


Company Profile
Company Contact
Name:Mr. Üâ²ÖÈð [Sales]
E-mail:Send Message
Mobile Number:Mobile number of Mr. Üâ²ÖÈð at ÎÞÎý
Phone Number:Phone number of Mr. Üâ²ÖÈð at ÎÞÎý
Address:Town ³ÎRoad 3698 No.
ÎÞÎý 214445, Jiangsu
China


无锡金昕生物科技有限公司
Company Brief

WUXI JINXIN BIOSCIENCES CO., LTDwas founded in 2013 It is an integrated chemistry CRO and CMO and focuses on developing pharmaceutical intermediates, peptide, cosmetic ingredients and dietary supplement ingredients, from lab scale to full scale manufacturing. After years of operation, our technological management team consists of experienced Ph.D. and M.S. who are familiar with the industry.

Located in Wuxi New District, 2 hour driving from Shanghai, China, JINXIN BIOSCIENCES is dedicated to provide the global biotechnology and pharmaceutical industries with professional chemistry services. We owns 53, 820 sft total standing alone R& D building in Wuxi with 13 synthetic labs, 1 kilo lab and 1 analytical lab. Our R& D building is equipped with Bruker 400MH NMR, Agilent 1200 HPLC, Analytical LCMS, Preparative LCMS, GCMS, Microwave synthesizers and other modern equipments. We have two cooperative plants with reactors from 50L to 5000L, low temperature vessels ( -80¡ æ ) and high pressure and temperature vessels ( 12MPa, 250¡ æ ) . Our compounds can be scaled up to tons in our manufacturing base with some other equipments, such as rectification column, muti-function workshop, clean workshop and so on.

We put top priority on the belief of super quality, punctual delivery, reasonable prices, best reputation and would like to have cooperate and create value with all customer for together.


Jiangsu
China











/common/images/branded/RA/images/30936_g5.jpgAriel View at the Ramada Parkview Hotel in Changzhou Jiangsu, ChinaChangzhou Jiangsu, China








Tongli village, Jiangsu, China.jpg